An overview of ferroptosis in non-alcoholic fatty liver disease

Biomed Pharmacother. 2022 Sep:153:113374. doi: 10.1016/j.biopha.2022.113374. Epub 2022 Jul 11.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a public health problem associated with high mortality and high morbidity rates worldwide. Presently, its complex pathophysiology is still unclear, and there is no specific drug to reverse NAFLD. Ferroptosis is an iron-dependent and non-apoptotic form of cell death characterized by the iron-induced accumulation of lipid reactive oxygen species (ROS), which damage nucleic acids, proteins, and lipids; generate intracellular oxidative stress; and ultimately cause cell death. Emerging evidence indicates that ferroptosis is involved in the progression of NAFLD, although the mechanism of action of ferroptosis in NAFLD is still poorly understood. Herein, we summarize the mechanism of action of ferroptosis in certain diseases, especially in the pathogenesis of NAFLD, and discuss the potential therapeutic approaches currently used to treat NAFLD. This review also highlights further directions for the treatment and prevention of NAFLD and related diseases.

Keywords: Ferroptosis; Non-alcoholic fatty liver disease; Oxidative stress; Therapy target.

Publication types

  • Review

MeSH terms

  • Ferroptosis*
  • Humans
  • Iron / metabolism
  • Liver / metabolism
  • Non-alcoholic Fatty Liver Disease* / metabolism
  • Oxidative Stress / physiology
  • Reactive Oxygen Species / metabolism

Substances

  • Reactive Oxygen Species
  • Iron